Healthcare - Biotechnology - NASDAQ - US
$ 66.29
-6.97 %
$ 11.9 B
Market Cap
-11.84
P/E
INCOME STATEMENT
305 M
REVENUE
-710 M
OPERATING INCOME
-750 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Insmed Incorporated
| Revenue | 305 M |
| Cost Of Revenue | 65.6 M |
| Gross Profit | 240 M |
| Operating Expenses | 949 M |
| Operating Income | -710 M |
| Other Expenses | 39.9 M |
| Net Income | -750 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Dec-2003 | Dec-2002 | Dec-2001 | Dec-2000 | Dec-1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||||||||||||||||||
| Revenue | 305.2 | 245.4 | 188.5 | 164.4 | 136.5 | 9.8 | 0 | 0 | 0 | 11.5 | 11.5 | 0 | 4.4 | 6.9 | 10.4 | 11.7 | 7.5 | 1.0 | 0.1 | 0.1 | 0.1 | 2.0 | 0.3 | 60 K | 0.7 |
| GROSS PROFIT | |||||||||||||||||||||||||
| Cost Of Revenue | 65.6 | 55.1 | 44.2 | 39.9 | 24.2 | 2.4 | 2.9 | 2.4 | 2.0 | 33.5 | 29.6 | 21.4 | 0 | 0 | 0 | 0 | 0.6 | 1.5 | 0 | 0 | 0 | 0 | 0 | 0 | 86.6 K |
| Gross Profit | 239.6 | 190.2 | 144.3 | 124.5 | 112.3 | 7.4 | (2.9) | (2.4) | (2.0) | (22.0) | (18.1) | (21.4) | 4.4 | 6.9 | 10.4 | 11.7 | 7.0 | (0.5) | 0.1 | 0.1 | 0.1 | 2.0 | 0.3 | 60 K | 0.7 |
| OPERATING INCOME | |||||||||||||||||||||||||
| Operating Expenses | 949.3 | 668.4 | 512.1 | 389.8 | 347.5 | 314.8 | 188.9 | 173.4 | 117.5 | 87.4 | 66.5 | 42.4 | 40.1 | 15.0 | 19.0 | 26.1 | 27.4 | 53.9 | 27.6 | 27.6 | 10.7 | 36.4 | 40.5 | 31.2 | 8.9 |
| Selling, General and Administrative Expenses | 344.5 | 265.8 | 234.3 | 203.6 | 210.8 | 168.2 | 79.2 | 50.7 | 43.2 | 31.1 | 22.2 | 12.7 | 12.2 | 10.3 | 9.8 | 5.1 | 8.5 | 25.7 | 5.7 | 4.2 | 3.5 | 3.0 | 5.0 | 9.6 | 2.4 |
| Research and Development Expenses | 571.0 | 397.5 | 272.7 | 181.2 | 131.7 | 145.3 | 109.7 | 122.7 | 74.3 | 56.3 | 44.3 | 29.8 | 27.9 | 4.8 | 9.2 | 21.0 | 18.9 | 21.1 | 21.8 | 23.3 | 7.1 | 18.1 | 35.5 | 21.6 | 6.3 |
| Operating Income | (709.6) | (478.1) | (367.8) | (265.2) | (235.2) | (307.3) | (188.9) | (173.4) | (117.5) | (87.4) | (55.0) | (42.4) | (61.7) | (8.1) | (8.7) | (14.4) | (20.4) | (54.4) | (27.4) | (27.4) | (10.6) | (37.0) | (40.2) | (81.5) | (8.1) |
| PRE-TAX INCOME | |||||||||||||||||||||||||
| Interest Income Expense | 76.3 | 26.4 | 40.5 | 29.6 | 27.7 | 25.5 | 5.9 | 3.5 | 2.9 | 2.4 | 2.4 | 0.8 | 10 K | 0.1 | 0.8 | 1.3 | (0.7) | (3.7) | (14.2) | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | (37.4) | (2.0) | (61.3) | (27.5) | (18.3) | (16.7) | (4.0) | (2.8) | (2.7) | (2.2) | (2.3) | (1.1) | (23.9) | 1.7 | 127.5 | (1.3) | 0.5 | (1.8) | (13.5) | 0.2 | 0.3 | 0.6 | 3.0 | 1.9 | 0 |
| Pre-Tax Income | (747.0) | (480.2) | (436.4) | (292.7) | (253.6) | (324.1) | (192.9) | (176.2) | (120.2) | (89.6) | (57.3) | (41.4) | (59.7) | (6.4) | 118.8 | (15.7) | (20.0) | (56.1) | (40.9) | (36.4) | (10.3) | (36.4) | (37.2) | (79.7) | 0 |
| NET INCOME | |||||||||||||||||||||||||
| Tax Provision | 2.6 | 1.4 | (1.8) | 1.4 | 0.8 | 0.2 | (0.3) | 98 K | (2.0) | (10.4) | (1.2) | 0.8 | 9.2 | 78 K | 0.5 | 1.3 | 0 | 1.8 | 0 | (9.2) | (0.3) | 1.9 | (74.3) | 0.2 | (0.3) |
| Net Income | (749.6) | (481.5) | (434.7) | (294.1) | (254.3) | (324.3) | (192.6) | (176.3) | (118.2) | (79.2) | (56.1) | (41.4) | (59.7) | (6.4) | 118.3 | (15.7) | (20.0) | (56.1) | (40.9) | (27.2) | (10.3) | (36.4) | (37.2) | (79.9) | (7.8) |
| EPS | 5.34 | 3.91 | 3.88 | 3.01 | 3.01 | 4.22 | 2.89 | 2.85 | 2.02 | 1.84 | 1.6 | 1.56 | 2.56 | 0.49 | 9.3 | 1.28 | 1.74 | 5.89 | 8.4 | 6.95 | 2.89 | 11 | 11.3 | 43.6 | 24.7 |